Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00703508 · ClinicalTrials.gov registry record · NA
Pharmacogenetics of Metformin Action in PCOS
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT00703508 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 55 participants.
The verdict
NCT00703508, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
1. The polycystic ovary syndrome is the major cause of infertility in the United States. Metformin has been shown to increase frequency of ovulations in PCOS, and is used in clinical practice to treat infertility, but some women with PCOS do not respond to metformin treatment. 2. Knowing that a specific gene predicts the effect of metformin on ovulation would facilitate more efficient and effective treatment of infertility in PCOS.
Interventions
- DRUG Metformin 500 mg tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-07 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00703508
The ClinicalTrials.gov registry entry for NCT00703508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin 500 mg tablet is the first listed.
NCT00703508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00703508 about?
NCT00703508 is a clinical study titled "Pharmacogenetics of Metformin Action in PCOS". 1. The polycystic ovary syndrome is the major cause of infertility in the United States. Metformin has been shown to increase frequency of ovulations in PCOS, and is used in clinical practice to treat infertility, but some women with PCOS do not respond to metformin treatment. 2. Knowing that a spec...
What is the current status of trial NCT00703508?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2008-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00703508?
The interventions under investigation include: Metformin 500 mg tablet (DRUG).
Who is sponsoring clinical trial NCT00703508?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.